Paul A. Bunn founded ApopLogic Pharmaceuticals, Inc.

He is on the board of ApopLogic Pharmaceuticals, Inc. and Verastem, Inc. and Professor at The University of Colorado School of Medicine.

In the past he was President, Chief Executive Officer & Director at International Association for the Study of Lung Cancer, President & Director at American Society of Clinical Oncology, President at Association of American Cancer Institutes and Head-Medical Oncology at The University of Colorado.

Paul A. Bunn received an undergraduate degree from Amherst College and a doctorate from Weill Cornell Medical College.